Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes}, Source: Eur Respir J 2012; 40: 657-664 Year: 2012
Changes of plasma von Willebrand factor in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004
Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac) Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Endotrophin and von Willebrand factor processing as predictive markers for mortality in the ECLIPSE COPD cohort Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect the severity of apnoeic episodes Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Unusually large von Willebrand factor multimers might be involved in cardiovascular events in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Expression of CD 34 and von Willebrand factor in pulmonary endothelium Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
PP308 – Endothelial injury in Chronic Obstructive Pulmonary Disease assessed by microalbuminuria (MAB) and von Willebrand factor levels and activity Source: ERS Lung Science Conference 2021 Year: 2021
Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006
Frequency and significance of vascular endothelial growth factor (VEGF) 936 C/T polymorphism in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Expression and significance of chemokine-like factor 1 in the lungs of patients with severe acute respiratory syndrome Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010
Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: ERS Lung Science Conference 2021 Year: 2021
Endothelin, endothelial cells and von Willenbrandt factor in peripheral blood in asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003
Impact of recombinant factor VIIa (rFVIIa) on transfusion related acute lung injury (TRALI) Source: Eur Respir J 2006; 28: Suppl. 50, 180s Year: 2006
ISTH Criteria for Disseminated Intravascular Coagulation (DIC) scale, Padua scale, D-dimer or Fibrinogen: what is the best predictor of COVID-19 pneumonia progression? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021